Read news on HBeAg with our app.
Read more in the app
Baseline liver fibrosis severity predicts superior HBeAg clearance and fibrosis reversal following peg-ifnα plus nucleos(t)ide analog therapy in HBeAg-positive chronic Hepatitis B patients